Cancer incidence variations are influenced by different factors including socioeconomic status, risk factors and use of screening. The purpose of this study was to examine trends in cancer incidence in two urban areas in Europe showing differences in influencing factors but also some common characteristics in the context of data quality of the corresponding cancer registries.
Methods
Age-standardized incidence rates (world standard – ASRW) for cases diagnosed in 2000–2009 for Sofia (Bulgaria) and the Canton of Zurich (Switzerland) were calculated using data from the corresponding cancer registries. Average annual percent change (AAPC) was estimated with Joinpoint regression analysis. Data quality was estimated in terms of proportions of microscopically verified (MV%) and deathcertificate-only (DCO%) cases.
Results
ASRWs for all sites were higher in Zurich for men (311 vs 262 per 100,000) and women (241 vs 231 per 100,000) than in Sofia. Colorectal (both sexes), lung (men), cervical and corpus uteri cancer had a higher incidence in Sofia. Prostate, breast and lung (women) cancer were more often diagnosed in Zurich. A significant increase in female lung cancer incidence was observed in both areas. Overall incidence decreased in Zurich, while it did not significantly change in Sofia. MV% was lower in Sofia than in the Canton of Zurich but increased steadily up to 85% in 2009, whereas in the Canton of Zurich MV% was more or less stable around 95%. The DCO% of Sofia was 19% in 2000 and steadily decreased to 8% in 2009. In the Canton of Zurich, the DCO% decreased from 5% in 2000 but increased again from 2006 onwards, up to 3% in 2009.
Conclusions
Cancer incidence rates differ between Sofia and Zurich. Differences concerning socioeconomic status, risk factors, use of cancer screening but also data quality may influence these results.
FormanD.B.F., Gombe MbalawaC., KohlerB., PicerosM., Steliarova-FoucherE., SwaminathanR., FerlayJ. (Eds): Cancer incidence in five continents, Volume X (electronic version: http://ci5.iarc.fr). IARC, Lyon, 2013.
2.
BlackR.J., BrayF., FerlayJ., ParkinD.M.: Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer, 33: 1075–1107, 1997.
3.
ArbynM., AntoineJ., MagiM., SmailyteG., StengrevicsA., SuteuO., ValerianovaZ., BrayF., WeiderpassE.: Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania. Int J Cancer, 128: 1899–1907, 2011.
4.
ArbynM., RaifuA.O., AutierP., FerlayJ.: Burden of cervical cancer in Europe: estimates for 2004. Ann Oncol, 18: 1708–1715, 2007.
5.
ValerianovaZ., PanayotovaY., AmatiC., BailiP.: Cervical cancer screening in Bulgaria-past and present experience. Tumori, 96: 538–544, 2010.
6.
DoubeniC.A., LaiyemoA.O., MajorJ.M., SchootmanM., LianM., ParkY., GraubardB.I., HollenbeckA.R., SinhaR.: Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer, 118: 3636–3644, 2012.
7.
DoubeniC.A., MajorJ.M., LaiyemoA.O., SchootmanM., ZauberA.G., HollenbeckA.R., SinhaR., AllisonJ.: Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst, 104: 1353–1362, 2012.
8.
LeufkensA.M., Van DuijnhovenF.J., BoshuizenH.C., SiersemaP.D., KunstA.E., MouwT., TjønnelandA., OlsenA., OvervadK., Boutron-RuaultM.C., Clavel-ChapelonF., MoroisS., KroghV., TuminoR., PanicoS., PolidoroS., PalliD., KaaksR., TeucherB., PischonT., TrichopoulouA., OrfanosP., GoufaI., PeetersP.H., SkeieG., BraatenT., RodríguezL., Lujan-BarrosoL., Sánchez-PérezM.J., NavarroC., BarricarteA., ZackrissonS., AlmquistM., HallmansG., PalmqvistR., TsilidisK.K., KhawK.T., WarehamN., GalloV., JenabM., RiboliE., Bueno-de-MesquitaH.B.: Educational level and risk of colorectal cancer in EPIC with specific reference to tumor location. Int J Cancer, 130: 622–630, 2012.
9.
MajorJ.M., Norman OliverM., DoubeniC.A., HollenbeckA.R., GraubardB.I., SinhaR.: Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study. Cancer Causes Control, 23: 1185–1191, 2012.
10.
WangF., LuoL., McLaffertyS.: Healthcare access, socioeconomic factors and late-stage cancer diagnosis: an exploratory spatial analysis and public policy implication. Int J Public Pol, 5: 237–258, 2010.
11.
PudrovskaT., AnikputaB.: The role of early-life socioeconomic status in breast cancer incidence and mortality: unraveling life course mechanisms. J Aging Health, 24: 323–344, 2012.
12.
BaquetC.R., CommiskeyP.: Socioeconomic factors and breast carcinoma in multicultural women. Cancer, 88(5 Suppl): 1256–1264, 2000.
13.
KriegerN.: Defining and investigating social disparities in cancer: critical issues. Cancer Causes Control, 16: 5–14, 2005.
14.
MilewskiI.: Identifying at-risk communities for action on cancer prevention: a case study in New Brunswick (Canada) communities. New Solut, 22: 79–107, 2012.
DonnellyD.W., HegartyA., SharpL., CarsinA.E., DeadyS., McCluskeyN., ComberH., GavinA.: The impact of adjustment for socioeconomic status on comparisons of cancer incidence between two European countries. J Cancer Epidemiol, 2013: 612514, 2013.
17.
CuradoM.P., VotiL., Sortino-RachouA.M.: Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care. Cancer Causes Control, 20: 751–756, 2009.
18.
WHO: Global status report on noncommunicable diseases 2010.World Health Organization, Geneva, 2011.
19.
FerlayJ., BurkhardC., WhelanS., ParkinD.M.: Check and conversion programs for cancer registries (IARC/IACR tools for cancer registries). IARC Technical Report, IARC, Lyon, 2005.
20.
CleggL.X., HankeyB.F., TiwariR., FeuerE.J., EdwardsB.K.: Estimating average annual per cent change in trend analysis. Stat Med, 28: 3670–3682, 2009.
21.
DikshitR.P., YeoleB.B., NagraniR., DhillonP., BadweR., BrayF.: Increase in breast cancer incidence among older women in Mumbai: 30-year trends and predictions to 2025. Cancer Epidemiol, 36: e215–e220, 2012.
22.
OldenT.E., ScholsJ.M., HamersJ.P., Van De SchansS.A., CoeberghJ.W., Janssen-HeijnenM.L.: Predicting the need for end-of-life care for elderly cancer patients: findings from a Dutch regional cancer registry database. Eur J Cancer Care (Engl), 21: 477–484, 2012.
23.
SwaminathanV., AudisioR.: Cancer in older patients: an analysis of elderly oncology. Ecancermedicalscience, 6: 243, 2012.
24.
TalaminiR., La VecchiaC., FranceschiS., ColomboF., DecarliA., GrattoniE., GrigolettoE., TognoniG.: Reproductive and hormonal factors and breast cancer in a northern Italian population. Int J Epidemiol, 14: 70–74, 1985.
25.
BulliardJ., La VecciaC., LeviF.: Diverging trends in breast cancer mortality within Switzerland. Ann Oncol, 17: 57–59, 2006.
26.
WarrenG.W., CummingsK.M.: Tobacco and lung cancer: risks, trends, and outcomes in patients with cancer. Am Soc Clin Oncol Educ Book, pp 359–364, 2013.
27.
CuradoM.P., EdwardsB., ShinH.R., StormH., FerlayJ., HeanueM. (Eds): Cancer incidence in five continents, Volume IX. IARC, Lyon, 2008.
28.
MoghaddamA.A., WoodwardM., HuxleyR.: Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev, 16: 2533–2547, 2007.
29.
LyngeE., AntillaA., ArbynM., SegnanN., RoncoG.: What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination. Eur J Cancer, 45: 2714–2721, 2009.
30.
VassilakosP., UntietS., PetignatP.: Cervical cancer prevention in Switzerland: the challenges of the vaccine era. Rev Med Suisse, 8: 2015–2016, 2018–2020, 2012.
31.
Neppl-HuberC., ZappaM., CoeberghJ.W., RapitiE., RachtanJ., HolleczekB., RossoS., AareleidT., BrennerH., GondosA.; EUNICE Survival Working Group: Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Ann Oncol, 23: 1325–1334, 2012.
32.
RowanS., RachetB., AlexeD.M., CooperN., ColemanM.P.: Survival from prostate cancer in England and Wales up to 2001. Br J Cancer, 99(Suppl 1): S75–77, 2008.
33.
RapitiE., FiorettaG., SchaffarR., Neyroud-CasparI., VerkooijenH.M., SchmidlinF., MiralbellR., ZanettiR., BouchardyC.: Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis. Cancer, 115: 5556–5565, 2009.
34.
VercelliM., QuagliaA., LilliniR.: Useful indicators to interpret tha cancer burden in Italy. Tumori, 99: 425–438, 2013.
35.
GattaG., RossiS., CapocacciaR.: Cancer burden estimates and forecasts: uses and cautions. Tumori, 99: 439–443, 2013.
36.
Steliarova-FoucherE., KaatschP., LacourB., Pompe-KirnV., EserS., MirandaA., DanzonA., RatiuA., ParkinD.M.: Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer, 42: 1915–1951, 2006.
37.
OberaignerW., SiebertU.: Are survival rates for Tyrol published in the Eurocare studies biased?Acta Oncol, 48: 984–991, 2009.
38.
HacklM., WaldhoerT.: Estimation of completeness of case ascertainment of Austrian cancer incidence data using the flow method. Eur J Public Health, 23: 889–893, 2013.
39.
BrennerH., JansenL.: Determinants and interpretation of death certificate only proportions in the initial years of newly established cancer registries. Eur J Cancer, 49: 931–937, 2013.
